|
1
|
Kyriakopoulos C, Zarkavelis G,
Andrianopoulou A, Papoudou-Bai A, Stefanou D, Boussios S and
Pentheroudakis G: Primary pulmonary malignant melanoma: Report of
an important entity and literature review. Case Rep Oncol Med.
2017:86543262017.PubMed/NCBI
|
|
2
|
Di L and Zhu WG: The role of H3K27me3
methylation in cancer development. Genome Instab Dis. 5:17–34.
2024. View Article : Google Scholar
|
|
3
|
Cortes-Ciriano I, Steele CD, Piculell K,
Al-Ibraheemi A, Eulo V, Bui MM, Chatzipli A, Dickson BC,
Borcherding DC, Feber A, et al: Genomic patterns of malignant
peripheral nerve sheath tumor (MPNST) evolution correlate with
clinical outcome and are detectable in cell-free DNA. Cancer
Discov. 13:654–671. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li H, Zheng L, Zhang X, Yu X, Zhong G,
Chen X, Chen X and Chen L: SH3 domainbinding glutamic acidrich
proteinlike 3 is associated with hyperglycemia and a poor outcome
in EpsteinBarr virusnegative gastric carcinoma. Oncol Lett.
29:82024. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu Z, Dong H, Wu J, Dong W, Guo X, Yu H,
Fang J, Gao S, Chen X, Lu H, et al: Targeted genomic profiling
revealed a unique clinical phenotype in intrahepatic
cholangiocarcinoma with fibroblast growth factor receptor
rearrangement. Transl Oncol. 14:1011682021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shi Y, Bing Z, Xu X and Cui Y: Primary
pulmonary malignant melanoma: Case report and literature review.
Thorac Cancer. 9:1185–1189. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kamposioras K, Pentheroudakis G,
Pectasides D and Pavlidis N: Malignant melanoma of unknown primary
site. To make the long story short. A systematic review of the
literature. Crit Rev Oncol Hematol. 78:112–126. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jensen OA and Egedorf J: Primary malignant
melanoma of the lung. Scand J Respir Dis. 48:127–135.
1967.PubMed/NCBI
|
|
9
|
Allen MS Jr and Drash EC: Primary melanoma
of the lung. Cancer. 21:154–159. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gaspard M, Lamant L, Tournier E, Valentin
T, Rochaix P, Terrier P, Ranchere-Vince D, Coindre JM, Filleron T
and Le Guellec S: Evaluation of eight melanocytic and neural
crest-associated markers in a well-characterised series of 124
malignant peripheral nerve sheath tumours (MPNST): Useful to
distinguish MPNST from melanoma? Histopathology. 73:969–982. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hrycaj SM, Szczepanski JM, Zhao L,
Siddiqui J, Thomas DG, Lucas DR, Patel RM, Harms PW, Bresler SC and
Chan MP: PRAME expression in spindle cell melanoma, malignant
peripheral nerve sheath tumour, and other cutaneous sarcomatoid
neoplasms: A comparative analysis. Histopathology. 81:818–825.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Le Guellec S, Macagno N, Velasco V, Lamant
L, Lae M, Filleron T, Malissen N, Cassagnau E, Terrier P, Chevreau
C, et al: Loss of h3k27 trimethylation is not suitable for
distinguishing malignant peripheral nerve sheath tumor from
melanoma: A study of 387 cases including mimicking lesions. Mod
Pathol. 30:1677–1687. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsuyama S, Kohsaka S, Hayashi T, Suehara
Y, Hashimoto T, Kajiyama Y, Tsurumaru M, Ueno T, Mano H, Yao T and
Saito T: Comprehensive clinicopathological and molecular analysis
of primary malignant melanoma of the oesophagus. Histopathology.
78:240–251. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Guan W, Ren W, Liu Z, Wu H, Chen Y,
Liu S, Quan X, Yang Z, Jiang C, et al: Longitudinal genomic
alternations and clonal dynamics analysis of primary malignant
melanoma of the esophagus. Neoplasia. 30:1008112022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tímár J and Ladányi A: Molecular pathology
of skin melanoma: Epidemiology, differential diagnostics, prognosis
and therapy prediction. Int J Mol Sci. 23:53842022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hou C, Xiao L, Ren X, Cheng L, Guo B,
Zhang M and Yan N: EZH2-mediated H3K27me3 is a predictive biomarker
and therapeutic target in uveal melanoma. Front Genet.
13:10134752022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Luo C, Balsa E, Perry EA, Liang J, Tavares
CD, Vazquez F, Widlund HR and Puigserver P: H3K27me3-mediated PGC1α
gene silencing promotes melanoma invasion through WNT5A and YAP. J
Clin Invest. 130:853–862. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hoffmann F, Niebel D, Aymans P,
Ferring-Schmitt S, Dietrich D and Landsberg J: H3K27me3 and EZH2
expression in melanoma: Relevance for melanoma progression and
response to immune checkpoint blockade. Clin Epigenetics.
12:242020. View Article : Google Scholar : PubMed/NCBI
|
